已建立的饮食干预措施和时间限制的饮食预防心血管疾病
You Jin Chang1, Leonie K Heilbronn2, Amy T Hutchison2
1Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia; Lifelong Health, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
Cell reports. Medicine
|September 4, 2025
概括
既定饮食和时间限制饮食 (TRE) 可以通过控制肥胖和代谢问题来改善心血管健康. 结合这些策略可以为心脏健康带来更大的好处.
科学领域:
- 心血管科学
- 营养科学
- 代谢健康
背景情况:
- 肥胖和代谢障碍 (胰岛素耐药性,炎症,高血压,脂质失调) 显著增加心血管风险.
- 已建立的饮食策略,如地中海饮食,DASH和卡路里限制 (CR),对于预防和治疗心血管疾病至关重要.
- 时间限制饮食 (TRE) 是一种间歇性禁食形式,包括限制每天的食物摄入时间为6-10小时,主要是在白天,这对心血管健康有好处.
研究的目的:
- 审查已确定的饮食策略和TRE改善心血管结果的证据.
- 探索这些饮食干预的潜在机制.
- 调查与TRE结合既定饮食的潜在协同心血管益处.
主要方法:
- 对有关饮食干预和心血管健康的现有研究进行了全面的文献审查.
- 分析连接饮食,新陈代谢和心血管疾病的机制路径.
- 探索组合饮食方法及其对心血管标志物的影响.
主要成果:
- 已建立的饮食 (地中海,DASH,CR) 在缓解心血管风险因素方面表现出有效性.
- 在改善新陈代谢参数和心血管健康指标方面,TRE具有潜力.
- 初步证据表明,与TRE结合既定饮食模式可能会增强心血管的益处.
结论:
- 饮食干预对于控制与肥胖有关的心血管风险至关重要.
- TRE 是改善心血管健康的有希望的策略.
- 需要进一步的研究来证实与TRE结合既定饮食的协同效应,以获得最佳的心血管结果.
相关概念视频
01:26Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
01:26Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
01:28Acute Coronary Syndrome IV: Interprofessional Care
25
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
25
01:27Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
01:27Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
01:30Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54